煙和尼古丁依賴症的全球市場 2023-2027
市場調查報告書
商品編碼
1161456

煙和尼古丁依賴症的全球市場 2023-2027

Global Smoking Cessation and Nicotine De-addiction Market 2023-2027

出版日期: | 出版商: TechNavio | 英文 120 Pages | 訂單完成後即時交付

價格

這份報告提供戒煙和尼古丁依賴症的市場規模在2023年~2027年間,預測將成長到245億2,975萬美元,在預測期間內預計將以12.59%的年複合成長率增長。網羅了本報告提供戒煙和尼古丁依賴症的市場相關資料,整體分析,市場規模與預測,趨勢,成長促進因素,課題,再加上約25家供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。

市場成長的主要因素有網路零售的引進增加,嘗試戒煙的人增加,消費者健康意識的提升。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模 2022
  • 市場預測:2022-2027年的預測

第4章 市場規模實際成果

  • 全球戒煙和尼古丁依賴症的市場2017~2021年
  • 流通管道市場區隔分析2017-2021
  • 產品市場區隔分析2017-2021
  • 地區市場區隔分析2017-2021
  • 國家市場區隔分析2017-2021

第5章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第6章 各流通管道市場區隔

  • 市場明細
  • 各流通管道比較
  • 藥妝店和零售業者 - 市場規模與預測 2022-2027
  • 醫院藥局 - 市場規模與預測 2022-2027
  • 網路零售 - 市場規模與預測 2022-2027
  • 各流通管道的市場機會

第7章 各產品的市場區隔

  • 市場明細
  • 各產品比較
  • 電子香煙 - 市場規模與預測 2022-2027
  • NRT - 市場規模與預測 2022-2027
  • 藥物療法 - 市場規模與預測 2022-2027
  • 各產品的市場機會

第8章 客戶形勢

  • 客戶形勢概要

第9章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測 2022-2027
  • 歐洲 - 市場規模與預測 2022-2027
  • 亞洲 - 市場規模與預測 2022-2027
  • 其他地區(ROW) - 市場規模與預測 2022-2027
  • 美國 - 市場規模與預測 2022-2027
  • 德國 - 市場規模與預測 2022-2027
  • 中國 - 市場規模與預測 2022-2027
  • 加拿大 - 市場規模與預測 2022-2027
  • 印度 - 市場規模與預測 2022-2027
  • 英國 - 市場規模與預測 2022-2027
  • 各地區形勢的市場機會

第10章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第11章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第12章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Alchem International Pvt. Ltd.
  • Alkalon AS
  • Alvogen
  • British American Tobacco Plc
  • Cambrex Corp.
  • Cipla Ltd.
  • Dr Reddys Laboratories Ltd.
  • Enorama Pharma AB
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Philip Morris International
  • Tvape

第13章 附錄

Product Code: IRTNTR40398

Technavio has been monitoring the smoking cessation and nicotine de-addiction market and is poised to grow by $24529.75 mn from 2023-2027, accelerating at a CAGR of 12.59% during the forecast period. Our report on the smoking cessation and nicotine de-addiction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising adoption of online retailing, the increasing number of people trying to quit smoking, and growing health awareness among consumers.

Technavio's smoking cessation and nicotine de-addiction market are segmented as below:

By Distribution Channel

  • Drug stores and retailers
  • Hospital pharmacies
  • Online retail

By Product

  • E-cigarette
  • NRT
  • Drug therapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the new marketing initiatives as one of the prime reasons driving the smoking cessation and nicotine de-addiction market growth during the next few years. Also, the rising number of organized retail outlets distributing nicotine patches and increasing availability through various distribution channels will lead to sizable demand in the market.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on smoking cessation and the nicotine de-addiction market covers the following areas:

  • Smoking cessation and nicotine de-addiction market sizing
  • Smoking cessation and nicotine de-addiction market forecast
  • Smoking cessation and nicotine de-addiction market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smoking cessation and nicotine de-addiction market vendors that include Alchem International Pvt. Ltd., Alkalon AS, Alvogen, Axcentria Pharmaceuticals, British American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. z o.o. Sp. k, Cipla Ltd., Dr. Reddys Laboratories Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson, Lil Drug Store Products Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris International, Qnovia, Tvape, and Walgreen Co. Also, the smoking cessation and nicotine de-addiction market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global smoking cessation and nicotine de-addiction market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global smoking cessation and nicotine de-addiction market 2017 - 2021 ($ million)
  • 4.2 Distribution channel Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Drug stores and retailers - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Drug stores and retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Drug stores and retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Drug stores and retailers - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Drug stores and retailers - Year-over-year growth 2022-2027 (%)
  • 6.4 Hospital pharmacies - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.5 Online retail - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Online retail - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Online retail - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Online retail - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Online retail - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by Distribution Channel
  • Exhibit 46: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 47: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 48: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 49: Chart on Comparison by Product
  • Exhibit 50: Data Table on Comparison by Product
  • 7.3 E-cigarette - Market size and forecast 2022-2027
  • Exhibit 51: Chart on E-cigarette - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on E-cigarette - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on E-cigarette - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on E-cigarette - Year-over-year growth 2022-2027 (%)
  • 7.4 NRT - Market size and forecast 2022-2027
  • Exhibit 55: Chart on NRT - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on NRT - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on NRT - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on NRT - Year-over-year growth 2022-2027 (%)
  • 7.5 Drug therapy - Market size and forecast 2022-2027
  • Exhibit 59: Chart on Drug therapy - Market size and forecast 2022-2027 ($ million)
  • Exhibit 60: Data Table on Drug therapy - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Chart on Drug therapy - Year-over-year growth 2022-2027 (%)
  • Exhibit 62: Data Table on Drug therapy - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Product
  • Exhibit 63: Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 67: Chart on Geographic comparison
  • Exhibit 68: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 India - Market size and forecast 2022-2027
  • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.12 UK - Market size and forecast 2022-2027
  • Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.13 Market opportunity By Geographical Landscape
  • Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 112: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 113: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 114: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 115: Matrix on vendor position and classification
  • 12.3 Alchem International Pvt. Ltd.
  • Exhibit 116: Alchem International Pvt. Ltd. - Overview
  • Exhibit 117: Alchem International Pvt. Ltd. - Product / Service
  • Exhibit 118: Alchem International Pvt. Ltd. - Key offerings
  • 12.4 Alkalon AS
  • Exhibit 119: Alkalon AS - Overview
  • Exhibit 120: Alkalon AS - Product / Service
  • Exhibit 121: Alkalon AS - Key offerings
  • 12.5 Alvogen
  • Exhibit 122: Alvogen - Overview
  • Exhibit 123: Alvogen - Product / Service
  • Exhibit 124: Alvogen - Key offerings
  • 12.6 British American Tobacco Plc
  • Exhibit 125: British American Tobacco Plc - Overview
  • Exhibit 126: British American Tobacco Plc - Business segments
  • Exhibit 127: British American Tobacco Plc - Key news
  • Exhibit 128: British American Tobacco Plc - Key offerings
  • Exhibit 129: British American Tobacco Plc - Segment focus
  • 12.7 Cambrex Corp.
  • Exhibit 130: Cambrex Corp. - Overview
  • Exhibit 131: Cambrex Corp. - Product / Service
  • Exhibit 132: Cambrex Corp. - Key news
  • Exhibit 133: Cambrex Corp. - Key offerings
  • 12.8 Cipla Ltd.
  • Exhibit 134: Cipla Ltd. - Overview
  • Exhibit 135: Cipla Ltd. - Business segments
  • Exhibit 136: Cipla Ltd. - Key news
  • Exhibit 137: Cipla Ltd. - Key offerings
  • Exhibit 138: Cipla Ltd. - Segment focus
  • 12.9 Dr Reddys Laboratories Ltd.
  • Exhibit 139: Dr Reddys Laboratories Ltd. - Overview
  • Exhibit 140: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibit 141: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibit 142: Dr Reddys Laboratories Ltd. - Segment focus
  • 12.10 Enorama Pharma AB
  • Exhibit 143: Enorama Pharma AB - Overview
  • Exhibit 144: Enorama Pharma AB - Product / Service
  • Exhibit 145: Enorama Pharma AB - Key news
  • Exhibit 146: Enorama Pharma AB - Key offerings
  • 12.11 Imperial Brands Plc
  • Exhibit 147: Imperial Brands Plc - Overview
  • Exhibit 148: Imperial Brands Plc - Business segments
  • Exhibit 149: Imperial Brands Plc - Key news
  • Exhibit 150: Imperial Brands Plc - Key offerings
  • Exhibit 151: Imperial Brands Plc - Segment focus
  • 12.12 Japan Tobacco Inc.
  • Exhibit 152: Japan Tobacco Inc. - Overview
  • Exhibit 153: Japan Tobacco Inc. - Business segments
  • Exhibit 154: Japan Tobacco Inc. - Key news
  • Exhibit 155: Japan Tobacco Inc. - Key offerings
  • Exhibit 156: Japan Tobacco Inc. - Segment focus
  • 12.13 Johnson and Johnson
  • Exhibit 157: Johnson and Johnson - Overview
  • Exhibit 158: Johnson and Johnson - Business segments
  • Exhibit 159: Johnson and Johnson - Key news
  • Exhibit 160: Johnson and Johnson - Key offerings
  • Exhibit 161: Johnson and Johnson - Segment focus
  • 12.14 Perrigo Co. Plc
  • Exhibit 162: Perrigo Co. Plc - Overview
  • Exhibit 163: Perrigo Co. Plc - Business segments
  • Exhibit 164: Perrigo Co. Plc - Key news
  • Exhibit 165: Perrigo Co. Plc - Key offerings
  • Exhibit 166: Perrigo Co. Plc - Segment focus
  • 12.15 Pfizer Inc.
  • Exhibit 167: Pfizer Inc. - Overview
  • Exhibit 168: Pfizer Inc. - Product / Service
  • Exhibit 169: Pfizer Inc. - Key news
  • Exhibit 170: Pfizer Inc. - Key offerings
  • 12.16 Philip Morris International
  • Exhibit 171: Philip Morris International - Overview
  • Exhibit 172: Philip Morris International - Business segments
  • Exhibit 173: Philip Morris International - Key offerings
  • Exhibit 174: Philip Morris International - Segment focus
  • 12.17 Tvape
  • Exhibit 175: Tvape - Overview
  • Exhibit 176: Tvape - Product / Service
  • Exhibit 177: Tvape - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 178: Inclusions checklist
  • Exhibit 179: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 180: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 181: Research methodology
  • Exhibit 182: Validation techniques employed for market sizing
  • Exhibit 183: Information sources
  • 13.5 List of abbreviations
  • Exhibit 184: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global smoking cessation and nicotine de-addiction market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Drug stores and retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Drug stores and retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Drug stores and retailers - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Drug stores and retailers - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Online retail - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Online retail - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Online retail - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Online retail - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Market opportunity by Distribution Channel ($ million)
  • Exhibits47: Chart on Product - Market share 2022-2027 (%)
  • Exhibits48: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits49: Chart on Comparison by Product
  • Exhibits50: Data Table on Comparison by Product
  • Exhibits51: Chart on E-cigarette - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Data Table on E-cigarette - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Chart on E-cigarette - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on E-cigarette - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Chart on NRT - Market size and forecast 2022-2027 ($ million)
  • Exhibits56: Data Table on NRT - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Chart on NRT - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on NRT - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Chart on Drug therapy - Market size and forecast 2022-2027 ($ million)
  • Exhibits60: Data Table on Drug therapy - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Chart on Drug therapy - Year-over-year growth 2022-2027 (%)
  • Exhibits62: Data Table on Drug therapy - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Market opportunity by Product ($ million)
  • Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits67: Chart on Geographic comparison
  • Exhibits68: Data Table on Geographic comparison
  • Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits102: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits103: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits107: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits108: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits109: Market opportunity By Geographical Landscape ($ million)
  • Exhibits110: Impact of drivers and challenges in 2022 and 2027
  • Exhibits111: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits112: Overview on factors of disruption
  • Exhibits113: Impact of key risks on business
  • Exhibits114: Vendors covered
  • Exhibits115: Matrix on vendor position and classification
  • Exhibits116: Alchem International Pvt. Ltd. - Overview
  • Exhibits117: Alchem International Pvt. Ltd. - Product / Service
  • Exhibits118: Alchem International Pvt. Ltd. - Key offerings
  • Exhibits119: Alkalon AS - Overview
  • Exhibits120: Alkalon AS - Product / Service
  • Exhibits121: Alkalon AS - Key offerings
  • Exhibits122: Alvogen - Overview
  • Exhibits123: Alvogen - Product / Service
  • Exhibits124: Alvogen - Key offerings
  • Exhibits125: British American Tobacco Plc - Overview
  • Exhibits126: British American Tobacco Plc - Business segments
  • Exhibits127: British American Tobacco Plc - Key news
  • Exhibits128: British American Tobacco Plc - Key offerings
  • Exhibits129: British American Tobacco Plc - Segment focus
  • Exhibits130: Cambrex Corp. - Overview
  • Exhibits131: Cambrex Corp. - Product / Service
  • Exhibits132: Cambrex Corp. - Key news
  • Exhibits133: Cambrex Corp. - Key offerings
  • Exhibits134: Cipla Ltd. - Overview
  • Exhibits135: Cipla Ltd. - Business segments
  • Exhibits136: Cipla Ltd. - Key news
  • Exhibits137: Cipla Ltd. - Key offerings
  • Exhibits138: Cipla Ltd. - Segment focus
  • Exhibits139: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits140: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits141: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits142: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits143: Enorama Pharma AB - Overview
  • Exhibits144: Enorama Pharma AB - Product / Service
  • Exhibits145: Enorama Pharma AB - Key news
  • Exhibits146: Enorama Pharma AB - Key offerings
  • Exhibits147: Imperial Brands Plc - Overview
  • Exhibits148: Imperial Brands Plc - Business segments
  • Exhibits149: Imperial Brands Plc - Key news
  • Exhibits150: Imperial Brands Plc - Key offerings
  • Exhibits151: Imperial Brands Plc - Segment focus
  • Exhibits152: Japan Tobacco Inc. - Overview
  • Exhibits153: Japan Tobacco Inc. - Business segments
  • Exhibits154: Japan Tobacco Inc. - Key news
  • Exhibits155: Japan Tobacco Inc. - Key offerings
  • Exhibits156: Japan Tobacco Inc. - Segment focus
  • Exhibits157: Johnson and Johnson - Overview
  • Exhibits158: Johnson and Johnson - Business segments
  • Exhibits159: Johnson and Johnson - Key news
  • Exhibits160: Johnson and Johnson - Key offerings
  • Exhibits161: Johnson and Johnson - Segment focus
  • Exhibits162: Perrigo Co. Plc - Overview
  • Exhibits163: Perrigo Co. Plc - Business segments
  • Exhibits164: Perrigo Co. Plc - Key news
  • Exhibits165: Perrigo Co. Plc - Key offerings
  • Exhibits166: Perrigo Co. Plc - Segment focus
  • Exhibits167: Pfizer Inc. - Overview
  • Exhibits168: Pfizer Inc. - Product / Service
  • Exhibits169: Pfizer Inc. - Key news
  • Exhibits170: Pfizer Inc. - Key offerings
  • Exhibits171: Philip Morris International - Overview
  • Exhibits172: Philip Morris International - Business segments
  • Exhibits173: Philip Morris International - Key offerings
  • Exhibits174: Philip Morris International - Segment focus
  • Exhibits175: Tvape - Overview
  • Exhibits176: Tvape - Product / Service
  • Exhibits177: Tvape - Key offerings
  • Exhibits178: Inclusions checklist
  • Exhibits179: Exclusions checklist
  • Exhibits180: Currency conversion rates for US$
  • Exhibits181: Research methodology
  • Exhibits182: Validation techniques employed for market sizing
  • Exhibits183: Information sources
  • Exhibits184: List of abbreviations